UNSPSC 51202400: Immunosupressant antibodies

This classification denotes immunoglobulin molecules that bear a specific amino acid sequence by virtue of which they interact exclusively with a related antigen or similar shape that induces their synthesis in lymphoid cells, molecules called antibodies, that reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT ANTIBODIES.

UNSPSC 51202400 Immunosuppressant antibodies is a Class code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's stated focus on immunosuppressant antibodies does not match the products actually being solicited under it in recent opportunities, which center on naloxone, emergency medical supplies, generic pharmaceuticals, and direct-to-manufacturer prescription programs. State and local buyers posting under this code include county health departments, municipal fire departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions across different tiers of government.

Recent opportunities span three states and include a Seminole County, Florida IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023); a Texas Health and Human Services Commission RFI for direct-to-manufacturer prescription capabilities (response deadline April 3, 2026); a City of Tampa IFB for 169 line items of medical and first aid supplies for the fire rescue division, estimated at $700,000, with a sheltered-market set-aside for certified small local business enterprises and a 5% SLBE bid discount (due March 13, 2026); and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and over-the-counter products serving state and local facilities across participating jurisdictions including Oregon, with proposals due March 26, 2026. The code exhibits fragmented activity and shows little relevant recent procurement momentum in its stated product category.